Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;26(1):10-28.
doi: 10.3348/kjr.2024.0963.

Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline

Eun Ju Ha #  1 , Min Kyoung Lee #  2 , Jung Hwan Baek  3 , Hyun Kyung Lim  4 , Hye Shin Ahn  5 , Seon Mi Baek  6 , Yoon Jung Choi  7 , Sae Rom Chung  8 , Ji-Hoon Kim  9 , Jae Ho Shin  10 , Ji Ye Lee  9 , Min Ji Hong  11 , Hyun Jin Kim  12 , Leehi Joo  8 , Soo Yeon Hahn  13 , So Lyung Jung  14 , Chang Yoon Lee  15 , Jeong Hyun Lee  8 , Young Hen Lee  16 , Jeong Seon Park  17 , Jung Hee Shin  13 , Jin Yong Sung  18 , Miyoung Choi  19 , Dong Gyu Na  20 ; Guideline Committee for the Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology
Affiliations
Review

Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline

Eun Ju Ha et al. Korean J Radiol. 2025 Jan.

Abstract

Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.

Keywords: Radiofrequency ablation; Thyroid; Thyroid intervention; Thyroid recurrent cancers; Ultrasound.

PubMed Disclaimer

Conflict of interest statement

Jung Hwan Baek: Consultant of radiofrequency company, STARmed since 2017.

References

    1. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014;273:241–260. - PMC - PubMed
    1. Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery. 2013;154:1448–1454. discussion 1454–1455. - PubMed
    1. Kim JH, Baek JH, Lim HK, Ahn HS, Baek SM, Choi YJ, et al. 2017 thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19:632–655. - PMC - PubMed
    1. Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. 2020 European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J. 2020;9:172–185. - PMC - PubMed
    1. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13:117–125. - PMC - PubMed

MeSH terms